|
06.06.2018 14:13:38
|
DGAP-News: STADA Arzneimittel AG: Annual General Meeting approves agenda items with a large majority
|
DGAP-News: STADA Arzneimittel AG / Key word(s): AGM/EGM Bad Vilbel, June 6, 2018 - STADA Arzneimittel AG announced today that the Company's shareholders approved all agenda items with a large majority that were put to a vote by the Executive Board and the Supervisory Board at the Annual General Meeting held on June 6, 2018 in Frankfurt/Main.
73.5 percent of the voting share capital were represented at the 2018 Annual General Meeting. Further details of the Annual General Meeting, including the voting results for each item on the agenda, are available on the STADA website at www.stada.com/agm2018.
Or visit us on the Internet at www.stada.com
06.06.2018 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. |
| Language: | English |
| Company: | STADA Arzneimittel AG |
| Stadastraße 2-18 | |
| 61118 Bad Vilbel | |
| Germany | |
| Phone: | +49 (0)6101 603- 113 |
| Fax: | +49 (0)6101 603- 506 |
| E-mail: | communications@stada.de |
| Internet: | www.stada.de |
| ISIN: | DE0007251803 |
| WKN: | 725180 |
| Indices: | SDAX |
| Listed: | Regulated Market in Dusseldorf, Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
| End of News | DGAP News Service |
|
|
693021 06.06.2018
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu STADAmehr Nachrichten
Analysen zu STADAmehr Analysen
Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.